Allograft tumor-bearing mice were first subjected to 5-FU (which increases the relative size of the LGR5+ compartment) followed by cessation of 5-FU therapy and start of DT treatment as to kill the LGR5+ cells (Fig. 8a; Supplementary Fig. 13a–c). The gene discussed is LGR5; the disease is neoplasm.